Notice 16 Apr 2025 regulation, controlled substances, oklahoma, drug enforcement administration, compliance, healthcare, medical licensing

⚖️Revocation of Medical Registration

The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Dr. Henry-Norbert O. Ndekwe's registration due to his lack of authority to handle controlled substances in Oklahoma. The document outlines the legal processes regarding the revocation and highlights the implications for healthcare practitioners and businesses in the industry.

Learn More
Notice 16 Apr 2025 medical practice, controlled substances, drug enforcement administration, new york, regulatory compliance, dea

⚖️DEA Revokes Registration of David Israel, M.D. for Misconduct

The Drug Enforcement Administration issued an order revoking David Israel, M.D.’s DEA registration due to unlawful prescription practices outside the usual course of professional practice. Allegations include issuing prescriptions for controlled substances without legitimate medical purpose, leading to significant legal and operational implications for the medical professional.

Learn More
Notice 16 Apr 2025 pharmacy, regulatory, controlled substances, compliance, pennsylvania, drug enforcement

💊DEA Revokes Registration of Empire and Skyline Pharmacies for Violations

The Drug Enforcement Administration issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy Inc. and Skyline Pharmacy Inc. for alleged violations concerning recordkeeping and dispensing of controlled substances. The order indicates potential revocation of their registration, deeming their operations inconsistent with public safety and legal standards.

Learn More
Notice 16 Apr 2025 georgia, controlled substances, regulatory compliance, healthcare, dea, dentistry

⚖️DEA Suspends Dentist's Registration Over Compliance Violations

The Drug Enforcement Administration has issued an Order to Show Cause and suspended the registration of Lona Bibbs-Walker, D.D.S., citing inadequate records on controlled substances and lack of state authority to practice. The order illustrates critical compliance issues in the healthcare industry, emphasizing the importance of strict adherence to regulatory standards.

Learn More
Notice 14 Apr 2025 regulatory compliance, dea, pharmaceutical industry, texas, controlled substances

💊DEA Revokes Eagle Pharmacy Registration

The Drug Enforcement Administration issued an Order to Show Cause against Eagle Pharmacy for alleged violations related to dispensing controlled substances without addressing significant red flags of abuse. The case highlights the stringent regulations governing pharmacies and the potential consequences of non-compliance, including revocation of licenses and operational disruptions.

Learn More
Notice 14 Apr 2025 regulation, pharmacy, compliance, dea, texas, controlled substances

💊DEA Revocation of Mariste Pharmacy's Registration - Overview

The Drug Enforcement Administration (DEA) has issued a decision revoking Mariste Pharmacy's registration due to significant violations related to controlled substances. Allegations include failure to address red flags of abuse in prescriptions and inadequate record-keeping, raising concerns for regulatory compliance and public health. The decision emphasizes the importance of adherence to laws governing drug dispensing and security.

Learn More
Notice 2 Apr 2025 compliance, regulatory, pharmaceuticals, california, dea, controlled substances

⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations

The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.

Learn More
Notice 1 Apr 2025 compliance, regulation, texas, controlled substances, drug enforcement, pharmacy

🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial

The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.

Learn More
Notice 27 Mar 2025 regulation, business compliance, dea, controlled substances, cannabis, drug enforcement

🍃DEA Notice on Bulk Manufacturing of Controlled Substances

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.

Learn More
Notice 27 Mar 2025 regulatory compliance, pharmaceutical industry, dea, controlled substances, business registration

💊SpecGx LLC Controlled Substances Import Application Overview

SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More